3 news items
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
MBRX
13 May 24
- long
Moleculin Reports Full Year 2023 Financial Results
MBRX
22 Mar 24
- long
A Preview Of Moleculin Biotech's Earnings
MBRX
21 Mar 24
56.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release
- Prev
- 1
- Next